Phase 2B study of tenecteplase (TNK) in acute ischemic stroke (TNK-S2B).

Trial Profile

Phase 2B study of tenecteplase (TNK) in acute ischemic stroke (TNK-S2B).

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms TNK-S2B
  • Most Recent Events

    • 26 Feb 2010 Results were presented at the 35th International Stroke Conference.
    • 25 Feb 2010 Status changed from active, no longer recruiting to discontinued, as reported in Stroke.
    • 25 Feb 2010 Results published in Stroke.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top